Location History:
- Nakhabino, RU (2015)
- Moscow, RU (2018)
Company Filing History:
Years Active: 2015-2018
Title: Inventor Profile: Tatiana I Solovyeva from Moscow
Introduction
Tatiana I Solovyeva is a distinguished inventor based in Moscow, Russia, recognized for her contributions to the field of medical diagnostics. With a focus on the Insulin-like Growth Factor Binding Protein-4 (IGFBP-4), her work has led to significant advancements in the detection of cardiovascular and cancer-related diseases.
Latest Patents
Tatiana holds two notable patents. The first patent, titled "Method for Detection of IGFBP-4 Fragments," discloses a method for detecting IGFBP-4 fragments utilizing antibodies or antigen binding fragments that specifically recognize epitopes on these fragments. These fragments include the N-terminal and C-terminal components resulting from PAPP-A dependent cleavage of IGFBP-4. The patent outlines assay and diagnostic methods that can employ the detection of IGFBP-4 fragments effectively.
Her second patent, "Diagnostic Kit for IGFBP-4 Proteolytic Fragments in a Patient Sample," relates to a method for diagnosing cardiovascular or cancer diseases through the identification of IGFBP-4 fragments in patient samples. This invention also highlights antibodies that specifically recognize novel epitopes produced by enzyme-dependent cleavage of IGFBP-4.
Career Highlights
Tatiana is currently associated with Hytest Ltd., where she continues to innovate in the realm of healthcare diagnostics. Her work has been instrumental in enhancing the understanding and detection of significant medical conditions, impacting the lives of many patients.
Collaborations
Throughout her career, Tatiana has collaborated with esteemed colleagues, including Alexey G Katrukha and Alexander B Postnikov. These collaborations have played a vital role in enhancing the scope of her research and the development of her patented technologies.
Conclusion
Tatiana I Solovyeva stands out as a prominent inventor in the field of medical diagnostics, with a focus on the detection of IGFBP-4 fragments. Her contributions through patents not only advance scientific knowledge but also pave the way for improved diagnostic methods in the medical community.